You are here: Industry Insights > Phase III trial

News List

China’s CanSino in talks for COVID vaccine Phase III trial overseas expresspharma
July 13, 2020
Phase III trials were likely to start “pretty soon,” and the company plans to recruit 40,000 participants for the tests.
CStone announces first patient dosed in the Phase III trial of CS1001 in combination with chemotherapy in first-line esophageal squamous cell carcinoma prnasia
January 09, 2020
CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Company's anti-PD-L1 antibody CS1001 in combination therapy as first-line treatment in patients with
Zydus Cadila announces phase III trial of Desidustat biospectrumasia
April 21, 2019
This Phase III study will be a multicenter (50- 60 sites), randomized, active-controlled clinical trial to evaluate the efficacy and safety of Desidustat versus Darbepoetin
Poteligeo approved in Europe for Mycosis Fungoides, Sézary Syndrome pharmatimes
November 27, 2018
Kyowa Hakko Kirin (Kyowa Kirin) has received marketing authorisation Europe for use of Poteligeo to treat Mycosis Fungoides and Sézary Syndrome, the two most common subtypes of cutaneous T-cell lymphoma, a rare type of non-Hodgkin’s lymphoma.